Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
We compare high-return candidates for Roth IRA indexing, analyzing volatility, fees, and potential tax-free compounding effects.
28,037 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
When a CEO sells shares, investors watch closely. This piece breaks down Exponent's move by Catherine Corrigan, expla...
Winter demand and a growing data-center footprint push grid strain. The Trump administration accelerates a coal reviv...
Bitcoin has seen shifts in on-chain dynamics that suggest selling pressure may be easing. Yet large holders continue ...
Anchorage Digital confirms it holds Strategy’s STRC perpetual preferred stock, marking a high-profile move by a regul...
Compass International and Rocket Companies announced an exclusive three-year alliance to syndicate Coming Soon and Pr...
This guide dives into credo tech (crdo) 2026 Q3 earnings expectations, key drivers, and how investors can position th...
As Omada Health eyes the 2025 earnings journey, investors want a clear read on growth, margins, and risks. This guide...
As market conditions shift in March 2026, traders seek better tools and pricing. This guide highlights the best SoFi ...
Former Indeed CEO Chris Hyams argues the real AI danger comes from the people steering the technology, not the code. ...
Robot dogs priced $300,000 are stepping into data-center security as AI investment surges. The four-legged guards pro...
Cleo Capital urges investors to recalibrate Nvidia's growth outlook as AI infrastructure spending moves from explosiv...